Prosthetic Heart Valve Market – Insights
Mechanical heart valve is an artificial heart valve implanted in the patient suffering from diseases such as aortic stenosis or mitral regurgitation. Pyrolytic carbon is used to manufacture mechanical heart valve, due to its strong and durable nature. There are two types of mechanical heart valves: mechanical aortic valve and mechanical mitral valve.

The global prosthetic heart valve market is estimated to account for US$ 21,968.6 Mn in terms of value by the end of 2027.

Global Prosthetic Heart Valve Market: Drivers

Increasing prevalence of valvular heart disease (VHD) is expected to boost growth of the global prosthetic heart valve market over the forecast period. For instance, according to the study, ‘Epidemiology and Trends of Aortic Stenosis Mortality in the United States (1999-2016)’, published in Journal of the American College of Cardiology in March 2019, aortic stenosis was associated with a mortality rate of 106.3 per 1 million persons, with highest mortality rate in non-Hispanic whites followed by Hispanics, and non-Hispanic blacks. Moreover, the study noticed increase in age-adjusted mortality between the periods.

Moreover, growing healthcare expenditure is also expected to aid in growth of the market. For instance, according to the Centers for Medicare & Medicaid Services (CMS), health spending in the U.S. is projected to grow at an average rate of 5.5% per year for 2018-27 and to reach nearly US$ 6.0 trillion by 2027.

North America region held dominant position in the global prosthetic heart valve market in 2019, accounting for 41.8% share in terms of value, followed by Europe.

Get PDF Brochure Of This Research Report @
https://www.coherentmarketinsights.com/insight/request-pdf/69

Global Prosthetic Heart Valve Market: Restraints

High cost of transcatheter heart valve products is expected to hinder growth of the global prosthetic heart valve market. For instance, the average cost of transcatheter aortic valve replacement (TAVR) devices is around US$ 32,000 as compared to US$ 4,000–US$ 7,000 for surgical valve devices and the average cost of TAVR and surgical procedure is US$ 37,900 and US$ 14,200, respectively.

Moreover, complications related to procedures are also expected to limit growth of the market. TAVR carries a risk of complications that may include, bleeding, stroke, blood vessel complications, kidney disease, heart rhythm abnormalities (arrhythmias), heart attack, and infection.

Global Prosthetic Heart Valve Market: Opportunities

Survival rate is high for mitral valve replacement among geriatric population suffering from valvular heart diseases, which is expected to increase demand for advanced prosthetic mitral valve implantation devices, thereby offering lucrative growth opportunities for players in the market.

Pregnant women treated with prosthetic mechanical heart valve are at high risk of complications such as thromboembolism during anticoagulation therapy. Therefore, manufacturers can focus on developing alternative prosthetic heart valve, which do not require anticoagulation therapy treatment after implantation for pregnant women.

Request Sample Copy of Research Report @
https://www.coherentmarketinsights.com/insight/request-sample/69

Global Prosthetic Heart Valve Market: Competitive Landscape

Major players operating in the global prosthetic heart valve market include, Edwards Lifesciences Corporation, Medtronic plc., Boston Scientific Corporation, Abbott Laboratories, LivaNova PLC, CryoLife, Inc., Braile Biomedica, Colibri Heart Valve, LLC, and JenaValve Technology, Inc.

Global Prosthetic Heart Valve Market: Key Developments

Major players in the market are focused on product approval and launch to expand their product portfolio. For instance, in November 2019, Edwards Lifesciences Corporation received CE Mark for Edwards SAPIEN 3 transcatheter heart valve for the treatment of patients diagnosed with aortic stenosis who are at low risk for open-heart surgery.

In April 2019, Boston Scientific Corporation received U.S. Food and Drug Administration (FDA) approval for the LOTUS Edge Aortic Valve System.

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]